Last updated: June 22, 2022
Sponsor: Szeged University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Psoriasis And Psoriatic Disorders
Rosacea
Warts
Treatment
N/AClinical Study ID
NCT05431959
SZEGEDU
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Diagnosis of plaque psoriasis for at least 6 months before the Baseline Visit
- Subject has stable mild to moderate plaque psoriasis
Exclusion
Exclusion Criteria:
- subject has systemic therapy for plaque psoriasis
- balneotherapy within 3 months prior the enrollement
- systemic/local glucocorticoid therapy within 1 month prior the enrollment
- general contraindications to balneotherapy: decompensated cardiovasculardisease;unstable hypertension, angina pectoris; uncontrolled endocrinedisease (hyperthyroidism, hyperparathyroidism); other uncontrolledand unstable metabolicdisorders (diabetes mellitus, hyperuricaemia,hyperlipoproteinaemia); acute febrileinfections; cutaneous suppuration;pregnancy; decompensated psychosis/neurosis,malignancy, urine and stool incontinent, unconsciousness, alcoholic influence, andlack of compliance.
Study Design
Total Participants: 16
Study Start date:
July 25, 2021
Estimated Completion Date:
August 15, 2022
Study Description
Connect with a study center
Tamas Bender
Budapest, 1025
HungaryActive - Recruiting
Ágota Kulisch, MD, PhD
Hévíz, 8380
HungaryActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.